ARCHIVES

With Fighter Planes Overhead, ODAC Kept Deliberating.

This article is from The Cancer Letter archive.

Vol. 27 No. 34 | September 21, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

Senators Urge study section On Clinical Cancer Research

February 4, 1994